Difficulty: Medium
Average Score: 95%
Practice
As the physician who is prescribing levodopa, you will note that the drug
Correct answer
B
Rationale
The correct answer is B) Fluctuates in its effectiveness with increasing frequency as treatment continues.
Levodopa is a precursor of dopamine used in the treatment of Parkinson's disease. It is known to exhibit a phenomenon called "wearing-off effect," where its effectiveness fluctuates over time with increasing frequency as treatment progresses. This is due to the progressive nature of Parkinson's disease, leading to fluctuations in response to treatment.
Option A is incorrect because carbidopa is actually given with levodopa to prevent its peripheral breakdown and enhance its central effects, not necessarily to reduce behavioral side effects.
Option C is incorrect because levodopa is not used to prevent extrapyramidal adverse effects of antipsychotic drugs. It is used specifically for Parkinson's disease symptoms.
Option D is incorrect because there is no evidence to support that levodopa protects against cancer in patients with melanoma. This statement is not related to the pharmacological action of levodopa.
In an educational context, understanding the pharmacokinetics and pharmacodynamics of levodopa is crucial for healthcare professionals managing patients with Parkinson's disease. Recognizing the wearing-off effect is essential for optimizing treatment regimens and improving patient outcomes. It is important to differentiate between the intended effects of a drug and its potential side effects or off-label uses to ensure safe and effective medication management.
Levodopa is a precursor of dopamine used in the treatment of Parkinson's disease. It is known to exhibit a phenomenon called "wearing-off effect," where its effectiveness fluctuates over time with increasing frequency as treatment progresses. This is due to the progressive nature of Parkinson's disease, leading to fluctuations in response to treatment.
Option A is incorrect because carbidopa is actually given with levodopa to prevent its peripheral breakdown and enhance its central effects, not necessarily to reduce behavioral side effects.
Option C is incorrect because levodopa is not used to prevent extrapyramidal adverse effects of antipsychotic drugs. It is used specifically for Parkinson's disease symptoms.
Option D is incorrect because there is no evidence to support that levodopa protects against cancer in patients with melanoma. This statement is not related to the pharmacological action of levodopa.
In an educational context, understanding the pharmacokinetics and pharmacodynamics of levodopa is crucial for healthcare professionals managing patients with Parkinson's disease. Recognizing the wearing-off effect is essential for optimizing treatment regimens and improving patient outcomes. It is important to differentiate between the intended effects of a drug and its potential side effects or off-label uses to ensure safe and effective medication management.